Genmab — Februar 2025
-
Wolfgang Miesbach
@miesbach
Excellent presentation by Dr. Sivapalaratnam #EAHAD2025, prophylactic treatment results of a phase 1/2 study using bispecific antibody HMB-001 https://x.com/miesbach/status/1887942918117167354 -
Brian O Mahony
@Brianhemophilia
Sivapalaratnam #EAHAD2025 on HMB-001 trial for Glanzmanns. Encouraging data with significant reduction in treated bleeds. This is a very difficult condition with ABR up to 80. New treatment options urgently required. https://x.com/Brianhemophilia/status/1888457175405572604 -
Nice graphic on how HMB-001 works in Glanzmanns. https://x.com/Brianhemophilia/status/1888457830392291557
-
Værdisætningen er helt væk, men hvor er bunden. Skal den ned i 1000 ved et nej til optionen ? Dagens bevægelse vise vel af der er mere elastik i prisen (nedaf) hvilket støttes af den dårlige volumebalance. Der er mere volume på vej ned end på vej op, så køberne er ikke til stede på dette niveau.
-
Selvom prisen ser rigtig god ud her, for den langesigtede investor, er jeg ikke i markedet fr den store indsats endnu. Men sidder klar med tørt krudt når beslutning om optionen er klar. Jeg håber at den skal op så snart usikkerheden er fjernet ligegyldigt om det er ja/nej. Men vil ikke sidde med -30% ved et nej og håbe på at prisen skal op når markedet for regnet på deres modeller.
-
there were a bunch of stops triggered. The previous low was 1357.50, so there were probably a few stops just below that. In the first minute almost 10.000 shares were traded; that is not pre-calculated trading, that is stops being hit. Every share sold is also bought, so there are just as many buys as sells...
-
Genmab Has First Wholly Owned Antibodies In Phase III, Hunts For More https://insights.citeline.com/scrip/business/deals/genmab-has-first-wholly-owned-antibodies-in-phase-iii-hunts-for-more-44FF7BFS4BFEJB5FMNSCIXFK5A/
-
Det økonomiske og Politiske usikkerheds index er på med indexet under Corona, alligevel fortsætter allerede dyre Tech aktier op af. I sidste uge lå Fear & Geed index i Fear idag kun i neutral alligevel sælges der ud af pharma og bankr. Verden er blevet skør og
optimismen er høj igen
Economic Policy Uncertainty Index
We develop a new method to measure economic policy uncertainty and test its dynamic relationship with output, investment, and employment. We find that, since 2008, economic policy uncertainty in the United States has been at a level approximately two times its long run average. We extend our approach to other countries, finding elevated levels of economic policy uncertainty abroad, as well.
(www.policyuncertainty.com)
-
Tænk hvis der kommer et bud på Genmab. Hvis buddet er på ca. 100% slipper byderen med ca. 2700 pr. aktie. For ca. 2 år siden var Genmab oppe omkring 3300 pr. aktie. De stærke kræfter der evt. er inde og spekulere over dette har gjort det godt, må man sige.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind